,doc_name,disease,induction method,species,conclusive_statement,therapeutic effect,intervention,MoA,strain,mechanism_of_action,induction
0,10738648.txt,rheumatoid arthritis,carrageenan-induced,rat,"In both these models, anti-inflammatory activity of 
liposomal indomethacin was significantly higher than that of free indomethacin 
(p < .01).",anti-inflammatory,liposomal indomethacin,,,,
1,10738648.txt,rheumatoid arthritis,adjuvant arthritis,rat,"In both these models, anti-inflammatory activity of 
liposomal indomethacin was significantly higher than that of free indomethacin 
(p < .01).",anti-inflammatory,liposomal indomethacin,,,,
2,11145023.txt,rheumatoid arthritis,adjuvant arthritis,rat,"These data demonstrate that IL-4 and IL-10 can exert powerful 
regulatory effects on neutrophil function that translate into a therapeutic 
response in a disease model of arthritis.",regulatory effects on neutrophil function,IL-4,,,,
3,11145023.txt,rheumatoid arthritis,adjuvant arthritis,rat,"These data demonstrate that IL-4 and IL-10 can exert powerful 
regulatory effects on neutrophil function that translate into a therapeutic 
response in a disease model of arthritis.",regulatory effects on neutrophil function,IL-10,,,,
4,11235018.txt,,collagen-induced arthritis,rat,"KF20444 
suppressed the development of arthritis",immunosuppressant,KF20444,"inhibitor 
of dihydroorotate dehydrogenase",Sprague Dawley,,
5,11237555.txt,rheumatoid arthritis.,"Collagen-induced 
arthritis",monkey,MRA may be an attractive agent for the treatment of rheumatoid arthritis.,,"humanized 
anti-human IL-6 receptor (IL-6R) antibody",,cynomolgus,react with monkey IL-6R,
6,11237555.txt,rheumatoid arthritis.,"Collagen-induced 
arthritis",monkey,MRA may be an attractive agent for the treatment of rheumatoid arthritis.,,"humanized 
anti-human IL-6 receptor (IL-6R) antibody",,cynomolgus,block signal transduction of IL-6,
7,11237555.txt,rheumatoid arthritis.,"Collagen-induced 
arthritis",monkey,MRA may be an attractive agent for the treatment of rheumatoid arthritis.,,MRA,,cynomolgus,react with monkey IL-6R,
8,11237555.txt,rheumatoid arthritis.,"Collagen-induced 
arthritis",monkey,MRA may be an attractive agent for the treatment of rheumatoid arthritis.,,MRA,,cynomolgus,block signal transduction of IL-6,
9,11249145.txt,rheumatoid arthritis,,mice,"The data from the SCW disease model suggests that RPR200765A 
could exhibit a profile of disease modifying activity in rheumatoid arthritis 
(RA) patients which is not observed with current drug therapies.",,RPR200765A,inhibitor of p38 MAP kinase,Balb/c,,streptococcal cell wall
10,11249145.txt,rheumatoid arthritis,,rat,"The data from the SCW disease model suggests that RPR200765A 
could exhibit a profile of disease modifying activity in rheumatoid arthritis 
(RA) patients which is not observed with current drug therapies.",,RPR200765A,inhibitor of p38 MAP kinase,Balb/c,,streptococcal cell wall
11,11249145.txt,rheumatoid arthritis,,mice,"The data from the SCW disease model suggests that RPR200765A 
could exhibit a profile of disease modifying activity in rheumatoid arthritis 
(RA) patients which is not observed with current drug therapies.",,RPR200765A,LPS-stimulated,Balb/c,,streptococcal cell wall
12,11249145.txt,rheumatoid arthritis,,rat,"The data from the SCW disease model suggests that RPR200765A 
could exhibit a profile of disease modifying activity in rheumatoid arthritis 
(RA) patients which is not observed with current drug therapies.",,RPR200765A,LPS-stimulated,Balb/c,,streptococcal cell wall
13,11359452.txt,rheumatoid arthritis,CIA,monkey,"Daclizumab has clinical potential for the treatment of RA during periods of 
active inflammation and suppression of the destruction of the joint tissues",joint-inflammation,Daclizumab,CD25,rhesus,,
14,11359452.txt,rheumatoid arthritis,CIA,monkey,"Daclizumab has clinical potential for the treatment of RA during periods of 
active inflammation and suppression of the destruction of the joint tissues",joint-erosion,Daclizumab,CD25,rhesus,,
15,11435459.txt,rheumatoid arthritis,"adjuvant-induced 
arthritis",rat,"Administration of 
SP600125 modestly decreased the rat paw swelling in rat adjuvant-induced 
arthritis.",,SP600125,,,JNK inhibitor,
16,11440118.txt,,Collagen-induced arthritis,mice,"Preimmunization of the mice with an extract of the house dust mite 
Dermatophagoides farinae (mite antigen), chicken ovalbumin, or keyhole limpet 
hemocyanin strongly inhibited CIA development",,Dermatophagoides farinae,,DBA/1J,,
17,11440118.txt,,Collagen-induced arthritis,mice,"Preimmunization of the mice with an extract of the house dust mite 
Dermatophagoides farinae (mite antigen), chicken ovalbumin, or keyhole limpet 
hemocyanin strongly inhibited CIA development",,mite antigen,,DBA/1J,,
18,11440118.txt,,Collagen-induced arthritis,mice,"Preimmunization of the mice with an extract of the house dust mite 
Dermatophagoides farinae (mite antigen), chicken ovalbumin, or keyhole limpet 
hemocyanin strongly inhibited CIA development",,"chicken ovalbumin,",,DBA/1J,,
19,11440118.txt,,Collagen-induced arthritis,mice,"Preimmunization of the mice with an extract of the house dust mite 
Dermatophagoides farinae (mite antigen), chicken ovalbumin, or keyhole limpet 
hemocyanin strongly inhibited CIA development",,"keyhole limpet 
hemocyanin",,DBA/1J,,
20,11440118.txt,,Collagen-induced arthritis,mice,"Preimmunization of the mice with an extract of the house dust mite 
Dermatophagoides farinae (mite antigen), chicken ovalbumin, or keyhole limpet 
hemocyanin strongly inhibited CIA development",,hen egg lysozyme,,DBA/1J,,
21,11440118.txt,,Collagen-induced arthritis,mice,"Preimmunization of the mice with an extract of the house dust mite 
Dermatophagoides farinae (mite antigen), chicken ovalbumin, or keyhole limpet 
hemocyanin strongly inhibited CIA development",,beta-lactoglobulin,,DBA/1J,,
22,11440118.txt,,Collagen-induced arthritis,mice,"Preimmunization of the mice with an extract of the house dust mite 
Dermatophagoides farinae (mite antigen), chicken ovalbumin, or keyhole limpet 
hemocyanin strongly inhibited CIA development",,myelin basic protein,,DBA/1J,,
23,11440118.txt,,Collagen-induced arthritis,mice,"hen egg lysozyme, 
beta-lactoglobulin from bovine milk or myelin basic protein from guinea pig 
brain did not substantially affect CIA development",,Dermatophagoides farinae,,DBA/1J,,
24,11440118.txt,,Collagen-induced arthritis,mice,"hen egg lysozyme, 
beta-lactoglobulin from bovine milk or myelin basic protein from guinea pig 
brain did not substantially affect CIA development",,mite antigen,,DBA/1J,,
25,11440118.txt,,Collagen-induced arthritis,mice,"hen egg lysozyme, 
beta-lactoglobulin from bovine milk or myelin basic protein from guinea pig 
brain did not substantially affect CIA development",,"chicken ovalbumin,",,DBA/1J,,
26,11440118.txt,,Collagen-induced arthritis,mice,"hen egg lysozyme, 
beta-lactoglobulin from bovine milk or myelin basic protein from guinea pig 
brain did not substantially affect CIA development",,"keyhole limpet 
hemocyanin",,DBA/1J,,
27,11440118.txt,,Collagen-induced arthritis,mice,"hen egg lysozyme, 
beta-lactoglobulin from bovine milk or myelin basic protein from guinea pig 
brain did not substantially affect CIA development",,hen egg lysozyme,,DBA/1J,,
28,11440118.txt,,Collagen-induced arthritis,mice,"hen egg lysozyme, 
beta-lactoglobulin from bovine milk or myelin basic protein from guinea pig 
brain did not substantially affect CIA development",,beta-lactoglobulin,,DBA/1J,,
29,11440118.txt,,Collagen-induced arthritis,mice,"hen egg lysozyme, 
beta-lactoglobulin from bovine milk or myelin basic protein from guinea pig 
brain did not substantially affect CIA development",,myelin basic protein,,DBA/1J,,
30,11469449.txt,rheumatoid arthritis,adjuvant arthritis,rat,"Tissue destruction, 
measured by radiographic and histopathologic scores, was reduced in a dose 
dependent manner with increasing MTX dose",,methotrexate,,Lewis,,
31,11469449.txt,rheumatoid arthritis,adjuvant arthritis,rat,"Suppression of tissue destruction and inflammation in rat AA does 
not occur in a concerted fashion as the dose of MTX increases.",,methotrexate,,Lewis,,
32,11550975.txt,rheumatoid arthritis,adjuvant arthritis,rat,"ML3000 is an antiarthritic drug with a high gastrointestinal 
tolerability, which can reduce synovial cell proliferation and joint erosion and 
is capable of markedly suppressing prostaglandin synthesis.",,ML3000,5-LOX,Lewis,,
33,11550975.txt,rheumatoid arthritis,adjuvant arthritis,rat,"ML3000 is an antiarthritic drug with a high gastrointestinal 
tolerability, which can reduce synovial cell proliferation and joint erosion and 
is capable of markedly suppressing prostaglandin synthesis.",,ML3000,COX-1 and COX-2,Lewis,,
34,11588111.txt,rheumatoid arthritis,(LPS)-stimulated,mouse,"Treatment with AF significantly inhibited IL-12 production in lipopolysaccharide 
(LPS)-stimulated macrophages and also in CD40L-stimulated dendritic cells.",,auranofin,inhibition of IL-12 production,macrophages,,
35,11588111.txt,rheumatoid arthritis,CD40L-stimulated,mouse,"Treatment with AF significantly inhibited IL-12 production in lipopolysaccharide 
(LPS)-stimulated macrophages and also in CD40L-stimulated dendritic cells.",,auranofin,inhibition of IL-12 production,macrophages,,
36,11588111.txt,rheumatoid arthritis,(LPS)-stimulated,mouse,"Treatment with AF significantly inhibited IL-12 production in lipopolysaccharide 
(LPS)-stimulated macrophages and also in CD40L-stimulated dendritic cells.",,auranofin,inhibition of IL-12 production,dendritic,,
37,11588111.txt,rheumatoid arthritis,CD40L-stimulated,mouse,"Treatment with AF significantly inhibited IL-12 production in lipopolysaccharide 
(LPS)-stimulated macrophages and also in CD40L-stimulated dendritic cells.",,auranofin,inhibition of IL-12 production,dendritic,,
38,11592381.txt,rheumatoid arthritis,collagen-induced arthritis,mice,"Mice treated with the transgene exhibited significant suppression of 
clinical symptoms such as disabling joint swelling, deformity, and hind paw 
thickness, compared with the untreated group",,Superoxide dismutase,,DBA/1,,
39,11592384.txt,rheumatoid arthritis,ovariectomy-induced,mouse,"These data indicate that HCT1026 is a potent inhibitor of bone 
resorption in vitro and protects against ovariectomy-induced bone loss in vivo",antiinflammatory,"flurbiprofen 
nitroxybutylester",Inhibitors of prostaglandin production,,,
40,11592385.txt,rheumatoid arthritis,interleukin-1alpha,mouse,demonstrated for the first time that the therapeutic effects,,triptolide,suppression of the production of proMMPs 1 and 3,J774A.1,,
41,11592385.txt,rheumatoid arthritis,interleukin-1alpha,mouse,demonstrated for the first time that the therapeutic effects,,triptolide,up-regulation of TIMPs,J774A.1,,
42,11592385.txt,rheumatoid arthritis,lipopolysaccharide,mouse,demonstrated for the first time that the therapeutic effects,,triptolide,suppression of the production of proMMPs 1 and 3,J774A.1,,
43,11592385.txt,rheumatoid arthritis,lipopolysaccharide,mouse,demonstrated for the first time that the therapeutic effects,,triptolide,up-regulation of TIMPs,J774A.1,,
44,11748266.txt,rheumatoid arthritis.,collagen-induced arthritis,mice,"These results demonstrate that neutralizing endogenous IL-18 is 
therapeutically efficacious in the murine model of collagen-induced arthritis",,"rabbit polyclonal anti-mouse 
IL-18 IgG",,DBA/1,,
45,11748266.txt,rheumatoid arthritis.,collagen-induced arthritis,mice,"These results demonstrate that neutralizing endogenous IL-18 is 
therapeutically efficacious in the murine model of collagen-induced arthritis",,recombinant human IL-18 binding protein,,DBA/1,,
46,11762952.txt,"rheumatoid 
arthritis.",collagen-induced arthritis,rats,"low molecular weight mimetic of SOD, M40403, 
attenuates the degree of chronic inflammation, tissue damage, and bone damage 
associated with CIA in the rat, and supports the possible use of SOD mimetics as 
therapeutic agents for the management of chronic diseases such as rheumatoid 
arthritis.",,M40403,,Lewis,,
47,11762952.txt,"rheumatoid 
arthritis.",collagen-induced arthritis,rats,"low molecular weight mimetic of SOD, M40403, 
attenuates the degree of chronic inflammation, tissue damage, and bone damage 
associated with CIA in the rat, and supports the possible use of SOD mimetics as 
therapeutic agents for the management of chronic diseases such as rheumatoid 
arthritis.",,superoxide dismutase,,Lewis,,
48,11791634.txt,rheumatoid arthritis,collagen-induced arthritis,mice,"L-asparaginase is a 
potent antiarthritic agent and may represent an effective second line agent for 
future treatment studies in juvenile and adult rheumatoid arthritis.",immunosuppressive,L-asparaginase,,DBA/1,,
49,11795518.txt,rheumatoid arthritis,TNF-alpha transgenic,mice,"Expressions of 
TNF-alpha and IL-6 were inhibited in the lungs of these mice after treatment",,Green tea,"inhibition of NF-kappaB and AP-1 
activation",,,
50,11822787.txt,rheumatoid arthritis,Adjuvant arthritis,rat,"Both monoclonal antibodies to PECAM-1 
and prednisolone significantly reduced adherent, but not rolling leukocytes in 
arthritic animals.",leukocyte adhesion,prednisolone,CD31,CD-rats,,
51,11822787.txt,rheumatoid arthritis,Adjuvant arthritis,rat,"Both monoclonal antibodies to PECAM-1 
and prednisolone significantly reduced adherent, but not rolling leukocytes in 
arthritic animals.",leukocyte adhesion,monoclonal antibodies to PECAM-1,CD31,CD-rats,,
52,11822787.txt,rheumatoid arthritis,Adjuvant arthritis,rat,"Both monoclonal antibodies to PECAM-1 
and prednisolone significantly reduced adherent, but not rolling leukocytes in 
arthritic animals.",leukocyte adhesion,prednisolone,CD31,CD-rats,,
53,11840456.txt,"rheumatoid 
arthritis",,mouse,"Vitamin E seems to uncouple joint inflammation and joint destruction 
in this model of RA, with a beneficial effect on joint destruction.",antioxidant,alpha-tocopherol,,KRN/NOD,,
54,11920418.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"In vivo blockade of IL-17 by muIL-17R:Fc treatment attenuated AIA 
and reduced joint damage",,muIL-17R:Fc,,DA,,
55,11949889.txt,rheumatoid arthritis,collagen-induced arthritis,mice,"an inhibitor of PECAM-1 might have therapeutic value for clinical 
treatment of rheumatoid arthritis.",,"anti-murine PECAM-1 
monoclonal antibody",,DBA/1J,PECAM-1,
56,11949889.txt,rheumatoid arthritis,collagen-induced arthritis,mice,"an inhibitor of PECAM-1 might have therapeutic value for clinical 
treatment of rheumatoid arthritis.",,2H8,,DBA/1J,PECAM-1,
57,11949889.txt,rheumatoid arthritis,collagen-induced arthritis,mice,"an inhibitor of PECAM-1 might have therapeutic value for clinical 
treatment of rheumatoid arthritis.",,dexamethasone,,DBA/1J,PECAM-1,
58,11958283.txt,rheumatoid arthritis,collagen-induced arthritis,mice,"The 
efficacy of NM-3 was greater than those of disease-modifying anti-rheumatoid 
drugs (DMARDs), auranofin (40 mg/kg/day) and bucillamine (10 mg/kg/day).",antiangiogenic,NM-3,,DBA/1J,,
59,11966757.txt,rheumatoid arthritis,Adjuvant arthritis,rats,"Early administration of PEG sTNF-RI did 
not attenuate AA, in contrast to an anti-TNF antibody, which suppressed disease",,PEG sTNF-RI,,DA,Anti-TNF,
60,11966757.txt,rheumatoid arthritis,Adjuvant arthritis,rats,"Early administration of PEG sTNF-RI did 
not attenuate AA, in contrast to an anti-TNF antibody, which suppressed disease",,anti-TNF antibody,,DA,Anti-TNF,
61,12012021.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"This compound 
thus offers a therapeutic potential for the treatment of chronic inflammatory 
diseases with an angiogenic component",anti-inflammatory,DTD,"inhibition of cytokine 
and PGE(2) production by interfering with NF-kappaB activation.",,,
62,12012021.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"This compound 
thus offers a therapeutic potential for the treatment of chronic inflammatory 
diseases with an angiogenic component",antiangiogenic,DTD,"inhibition of cytokine 
and PGE(2) production by interfering with NF-kappaB activation.",,,
63,12126975.txt,rheumatoid arthritis.,"carrageenin-, 
zymosan-, or dextran-induced",rats,"diacerein inhibited the 
rat paw edema induced by various agents.",,Diacerein,,,,
64,12126975.txt,rheumatoid arthritis.,"carrageenin-, 
zymosan-, or dextran-induced",rats,"In the adjuvant-induced arthritic rats, 
diacerein at 100 mg/kg/day significantly suppressed the paw edema and the 
increase in serum mucoprotein.",,Diacerein,,,,
65,12126975.txt,rheumatoid arthritis.,"carrageenin-, 
zymosan-, or dextran-induced",rats,"In the ovariectomized rats, 
diacerein (10, 100 mg/kg/day) also significantly prevented bone loss and reduced 
the serum alkaline phosphatase and decreased the excretion of urinary 
hydroxyproline.",,Diacerein,,,,
66,12126975.txt,rheumatoid arthritis.,adjuvant-induced arthritis,rats,"diacerein inhibited the 
rat paw edema induced by various agents.",,Diacerein,,,,
67,12126975.txt,rheumatoid arthritis.,adjuvant-induced arthritis,rats,"In the adjuvant-induced arthritic rats, 
diacerein at 100 mg/kg/day significantly suppressed the paw edema and the 
increase in serum mucoprotein.",,Diacerein,,,,
68,12126975.txt,rheumatoid arthritis.,adjuvant-induced arthritis,rats,"In the ovariectomized rats, 
diacerein (10, 100 mg/kg/day) also significantly prevented bone loss and reduced 
the serum alkaline phosphatase and decreased the excretion of urinary 
hydroxyproline.",,Diacerein,,,,
69,12126975.txt,rheumatoid arthritis.,ovariectomized,rats,"diacerein inhibited the 
rat paw edema induced by various agents.",,Diacerein,,,,
70,12126975.txt,rheumatoid arthritis.,ovariectomized,rats,"In the adjuvant-induced arthritic rats, 
diacerein at 100 mg/kg/day significantly suppressed the paw edema and the 
increase in serum mucoprotein.",,Diacerein,,,,
71,12126975.txt,rheumatoid arthritis.,ovariectomized,rats,"In the ovariectomized rats, 
diacerein (10, 100 mg/kg/day) also significantly prevented bone loss and reduced 
the serum alkaline phosphatase and decreased the excretion of urinary 
hydroxyproline.",,Diacerein,,,,
72,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",chick,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,chorioallantoic membranes,HMG-CoA reductase inhibitor,
73,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",chick,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,corneas,HMG-CoA reductase inhibitor,
74,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",mouse,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,chorioallantoic membranes,HMG-CoA reductase inhibitor,
75,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",mouse,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,corneas,HMG-CoA reductase inhibitor,
76,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",chick,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,chorioallantoic membranes,"fibroblast growth 
factor-stimulated",
77,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",chick,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,corneas,"fibroblast growth 
factor-stimulated",
78,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",mouse,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,chorioallantoic membranes,"fibroblast growth 
factor-stimulated",
79,12142347.txt,rheumatoid arthritis,"vascular endothelial growth 
factor-stimulated",mouse,dose-dependently inhibited capillary growth,antiangiogenic,simvastatin,,corneas,"fibroblast growth 
factor-stimulated",
80,12180723.txt,"rheumatoid 
arthritis",,mice,"ISA(TX)247 demonstrates efficacy and safety in the treatment of 
established collagen induced arthritis.",,ISA(TX)247,calcineurin inhibitor,DBA/Lac J,,collagen induced arthritis
81,12355496.txt,rheumatoid arthritis.,intraarticular injection of methylated bovine serum albumin,rats,"Rats receiving AcF-[OPdChaWR] had significant reductions in right knee 
swelling, gait disturbance, lavaged joint cell numbers, and right knee 
histopathology, as well as in serum levels of tumor necrosis factor alpha 
(TNFalpha) and intraarticular levels of interleukin-6 and TNFalpha on day 14.",,AcF-[OPdChaWR],C5a receptor antagonist,,,
82,12355496.txt,rheumatoid arthritis.,intraarticular injection of methylated bovine serum albumin,rats,"In 
the 14- and 28-day studies, ibuprofen resulted in a similar reduction in gait 
abnormalities and intraarticular inflammatory cells compared with the C5a 
antagonist, but was less effective in reducing knee swelling over the course of 
the study and had no effect on knee histopathology.",,AcF-[OPdChaWR],C5a receptor antagonist,,,
83,12355496.txt,rheumatoid arthritis.,intraarticular injection of methylated bovine serum albumin,rats,"Rats receiving AcF-[OPdChaWR] had significant reductions in right knee 
swelling, gait disturbance, lavaged joint cell numbers, and right knee 
histopathology, as well as in serum levels of tumor necrosis factor alpha 
(TNFalpha) and intraarticular levels of interleukin-6 and TNFalpha on day 14.",,ibuprofen,C5a receptor antagonist,,,
84,12355496.txt,rheumatoid arthritis.,intraarticular injection of methylated bovine serum albumin,rats,"In 
the 14- and 28-day studies, ibuprofen resulted in a similar reduction in gait 
abnormalities and intraarticular inflammatory cells compared with the C5a 
antagonist, but was less effective in reducing knee swelling over the course of 
the study and had no effect on knee histopathology.",,ibuprofen,C5a receptor antagonist,,,
85,12396022.txt,,,mouse,"The 
MC-stabilizer had efficacy in a mouse model.",,Rheumatoid arthritis,"MC-stabilizing compound,",,,
86,12396022.txt,,,mouse,"The 
MC-stabilizer had efficacy in a mouse model.",,cromoglicate lisetil,"MC-stabilizing compound,",,,
87,12510369.txt,"rheumatoid 
arthritis","collagen 
inducing arthritis",monkeys,These evidence suggest that MRA has anti-arthritic effects.,,MRA,,cynomolgus,inhibits IL-6,
88,12516467.txt,"rheumatoid 
arthritis",Adjuvant arthritis,rats (,"The Prescription at high and medium dosages significantly decreased the 
rising level of hydrogen peroxide and interleukin-1",,prednisone,,,,
89,12528470.txt,rheumatoid arthritis,adjuvant arthritis,rat,"The therapeutic range of meloxicam in the rat, with 
regard to inhibition of adjuvant arthritis, was several times greater than that 
of other NSAIDs.",NSAID,Meloxicam,cyclooxygenase,,,
90,12658918.txt,rheumatoid arthritis,CIA,rats,"BZX decoction and MTX could decrease the expression of VEGF, but the 
curative effect of BZX decoction is significantly better than that of MTX.",,bizhongxiao,,SD,,
91,12688421.txt,rheumatoid arthritis,CIA,rats,"The results indicate that the GAGs HYA and C4S 
significantly reduce free radical production in CIA",antioxidant,hyaluronic acid,,Lewis,,
92,12688421.txt,rheumatoid arthritis,CIA,rats,"The results indicate that the GAGs HYA and C4S 
significantly reduce free radical production in CIA",antioxidant,chondroitin-4-sulphate,,Lewis,,
93,12699411.txt,rheumatoid arthritis,IFN-gamma + LPS-stimulated,mouse,MPA exerted dose-dependent inhibition of NO synthesis,,mycophenolic acid,"inhibit the enzymatic activity of inducible NO synthase 
(iNOS) and subsequent production of the cytotoxic free radical nitric oxide (NO)",L929,,
94,12699411.txt,rheumatoid arthritis,IFN-gamma + LPS-stimulated,rat,MPA exerted dose-dependent inhibition of NO synthesis,,mycophenolic acid,"inhibit the enzymatic activity of inducible NO synthase 
(iNOS) and subsequent production of the cytotoxic free radical nitric oxide (NO)",L929,,
95,12709543.txt,rheumatoid arthritis.,collagen-induced arthritis,mice,Administration of PG201 has therapeutic effects on CIA,anti-inflammatory,PG201,,DBA/1,,
96,12723984.txt,rheumatoid arthritis.,"collagen-induced 
arthritis",rat,"Treatment with HYA and C4S, starting at the onset of arthritis for 10 days, 
limited the erosive action of the disease in the articular joints of knee and 
paw, reduced lipid peroxidation, restored the endogenous antioxidants reduced 
glutathione (GSH) and superoxide dismutase, decreased plasma TNF-alpha levels, 
and limited synovial neutrophil infiltration.",antioxidant,hyaluronic acid,,Lewis,,
97,12723984.txt,rheumatoid arthritis.,"collagen-induced 
arthritis",rat,"Treatment with HYA and C4S, starting at the onset of arthritis for 10 days, 
limited the erosive action of the disease in the articular joints of knee and 
paw, reduced lipid peroxidation, restored the endogenous antioxidants reduced 
glutathione (GSH) and superoxide dismutase, decreased plasma TNF-alpha levels, 
and limited synovial neutrophil infiltration.",antioxidant,chondroitin-4-sulphate,,Lewis,,
98,14561094.txt,rheumatoid arthritis,carrageenan paw edema,rat,"IC(50) = 
0.47 nM, 47% inhibition of paw swelling at 10 mg/kg in rat carrageenan paw edema 
model)",antiinflammatory,GP790,adenosine kinase inhibitors,,,
99,14568965.txt,rheumatoid arthritis,,mice,Treatment with anti-VEGF-RII had no effect.,,anti-mouse VEGF Ab,VEGF,K/BxN,,
100,14568965.txt,rheumatoid arthritis,,mice,"Anti-VEGF-RI reduced the intensity 
of clinical manifestations",,anti-mouse VEGF Ab,VEGF,K/BxN,,
101,14568965.txt,rheumatoid arthritis,,mice,"Treatment with a VEGF-RI tyrosine 
kinase inhibitor almost abolished the disease.",,anti-mouse VEGF Ab,VEGF,K/BxN,,
102,14568965.txt,rheumatoid arthritis,,mice,Treatment with anti-VEGF-RII had no effect.,,"anti-mouse 
VEGF-RI and -RII Abs",VEGF,K/BxN,,
103,14568965.txt,rheumatoid arthritis,,mice,"Anti-VEGF-RI reduced the intensity 
of clinical manifestations",,"anti-mouse 
VEGF-RI and -RII Abs",VEGF,K/BxN,,
104,14568965.txt,rheumatoid arthritis,,mice,"Treatment with a VEGF-RI tyrosine 
kinase inhibitor almost abolished the disease.",,"anti-mouse 
VEGF-RI and -RII Abs",VEGF,K/BxN,,
105,14568965.txt,rheumatoid arthritis,,mice,Treatment with anti-VEGF-RII had no effect.,,inhibitor of VEGF-RI tyrosine kinase.,VEGF,K/BxN,,
106,14568965.txt,rheumatoid arthritis,,mice,"Anti-VEGF-RI reduced the intensity 
of clinical manifestations",,inhibitor of VEGF-RI tyrosine kinase.,VEGF,K/BxN,,
107,14568965.txt,rheumatoid arthritis,,mice,"Treatment with a VEGF-RI tyrosine 
kinase inhibitor almost abolished the disease.",,inhibitor of VEGF-RI tyrosine kinase.,VEGF,K/BxN,,
108,14568965.txt,rheumatoid arthritis.,,mice,Treatment with anti-VEGF-RII had no effect.,,anti-mouse VEGF Ab,VEGF,K/BxN,,
109,14568965.txt,rheumatoid arthritis.,,mice,"Anti-VEGF-RI reduced the intensity 
of clinical manifestations",,anti-mouse VEGF Ab,VEGF,K/BxN,,
110,14568965.txt,rheumatoid arthritis.,,mice,"Treatment with a VEGF-RI tyrosine 
kinase inhibitor almost abolished the disease.",,anti-mouse VEGF Ab,VEGF,K/BxN,,
111,14568965.txt,rheumatoid arthritis.,,mice,Treatment with anti-VEGF-RII had no effect.,,"anti-mouse 
VEGF-RI and -RII Abs",VEGF,K/BxN,,
112,14568965.txt,rheumatoid arthritis.,,mice,"Anti-VEGF-RI reduced the intensity 
of clinical manifestations",,"anti-mouse 
VEGF-RI and -RII Abs",VEGF,K/BxN,,
113,14568965.txt,rheumatoid arthritis.,,mice,"Treatment with a VEGF-RI tyrosine 
kinase inhibitor almost abolished the disease.",,"anti-mouse 
VEGF-RI and -RII Abs",VEGF,K/BxN,,
114,14568965.txt,rheumatoid arthritis.,,mice,Treatment with anti-VEGF-RII had no effect.,,inhibitor of VEGF-RI tyrosine kinase.,VEGF,K/BxN,,
115,14568965.txt,rheumatoid arthritis.,,mice,"Anti-VEGF-RI reduced the intensity 
of clinical manifestations",,inhibitor of VEGF-RI tyrosine kinase.,VEGF,K/BxN,,
116,14568965.txt,rheumatoid arthritis.,,mice,"Treatment with a VEGF-RI tyrosine 
kinase inhibitor almost abolished the disease.",,inhibitor of VEGF-RI tyrosine kinase.,VEGF,K/BxN,,
117,14648391.txt,rheumatoid arthritis,Freund's complete adjuvant reagent FCA-treated,rats,"significantly decreased RA and CRP factors, the former being more 
active than the latter.",,Rhus verniciflua,inhibiting reactive oxygen species,,,
118,14648391.txt,rheumatoid arthritis,Freund's complete adjuvant reagent FCA-treated,rats,"significantly decreased RA and CRP factors, the former being more 
active than the latter.",,sulfuretin,inhibiting reactive oxygen species,,,
119,14648391.txt,rheumatoid arthritis,Freund's complete adjuvant reagent FCA-treated,rats,"significantly decreased RA and CRP factors, the former being more 
active than the latter.",,fustin,inhibiting reactive oxygen species,,,
120,14696674.txt,rheumatoid arthritis,collagen-induced arthritis,rat,"It was observed that the articular morphological alterations, the 
over-expression of MMP-3 mRNA and the reduced production of TIMP-1 in CIA rats 
were significantly ameliorated by QLY.","suppressive effect 
on the angiogenesis",Qing-Luo-Yin,,,,
121,14872511.txt,rheumatoid arthritis,"anti-type II collagen 
monoclonal antibody",mice,"Treatment with recombinant FRP showed significant amelioration of the 
arthritis severity.",,follistatin-related protein,,BALB/c,,
122,14872511.txt,rheumatoid arthritis,lipopolysaccharide,mice,"Treatment with recombinant FRP showed significant amelioration of the 
arthritis severity.",,follistatin-related protein,,BALB/c,,
123,14991082.txt,,collagen-induced arthritis,rats,"These results show that FK506 is effective in suppressing 
inflammation, TNF-alpha expression in joint, and damage to bone and cartilage in 
rat CIA, and may be useful in the treatment of rheumatoid arthritis.",,tacrolimus,,Lewis,,
124,15022325.txt,rheumatoid arthritis,Antigen-induced arthritis,mice,"These results suggest that ChM-I suppresses T cell responses and 
synovial cell proliferation, implying that this cartilage matrix protein has a 
therapeutic potential in RA.","promotes the 
growth and proteoglycan synthesis of chondrocytes",Chondromodulin I,,,,
125,15022325.txt,rheumatoid arthritis,Antigen-induced arthritis,mice,"These results suggest that ChM-I suppresses T cell responses and 
synovial cell proliferation, implying that this cartilage matrix protein has a 
therapeutic potential in RA.","inhibits 
angiogenesis",Chondromodulin I,,,,
126,15031542.txt,rheumatoid arthritis,LPS-induced,rat,"In 
both experiments, BLF suppressed the development of arthritis and the 
hyperalgesia in the adjuvant-injected paw.",immunomodulator,Lactoferrin,,,,
127,15031542.txt,rheumatoid arthritis,"adjuvant 
arthritis",rat,"In 
both experiments, BLF suppressed the development of arthritis and the 
hyperalgesia in the adjuvant-injected paw.",immunomodulator,Lactoferrin,,,,
128,15031542.txt,rheumatoid arthritis,LPS-induced,rat,"In 
both experiments, BLF suppressed the development of arthritis and the 
hyperalgesia in the adjuvant-injected paw.",anti-nociceptive,Lactoferrin,,,,
129,15031542.txt,rheumatoid arthritis,"adjuvant 
arthritis",rat,"In 
both experiments, BLF suppressed the development of arthritis and the 
hyperalgesia in the adjuvant-injected paw.",anti-nociceptive,Lactoferrin,,,,
130,15031542.txt,rheumatoid arthritis,LPS-induced,rat,"In 
both experiments, BLF suppressed the development of arthritis and the 
hyperalgesia in the adjuvant-injected paw.",anti-inflammatory,Lactoferrin,,,,
131,15031542.txt,rheumatoid arthritis,"adjuvant 
arthritis",rat,"In 
both experiments, BLF suppressed the development of arthritis and the 
hyperalgesia in the adjuvant-injected paw.",anti-inflammatory,Lactoferrin,,,,
132,15059273.txt,rheumatoid arthritis.,collagen-induced arthritis,mouse,"The therapeutic effect of dTNFR expressed from a 
constitutive or regulated plasmid was dependent on the degree of disease 
activity at the time of DNA injection.",,dTNFR,inhibit TNF-alpha,,,
133,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
134,15060719.txt,,antigen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
135,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
136,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
137,15060719.txt,,antigen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
138,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
139,15060719.txt,,antigen-induced arthritis,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
140,15060719.txt,,antigen-induced arthritis,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
141,15060719.txt,,antigen-induced arthritis,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
142,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
143,15060719.txt,,antigen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
144,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
145,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
146,15060719.txt,,antigen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
147,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
148,15060719.txt,,antigen-induced arthritis,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
149,15060719.txt,,antigen-induced arthritis,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
150,15060719.txt,,antigen-induced arthritis,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
151,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
152,15060719.txt,,antigen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
153,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
154,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
155,15060719.txt,,antigen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
156,15060719.txt,,antigen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
157,15060719.txt,,antigen-induced arthritis,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
158,15060719.txt,,antigen-induced arthritis,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
159,15060719.txt,,antigen-induced arthritis,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
160,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
161,15060719.txt,,collagen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
162,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
163,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
164,15060719.txt,,collagen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
165,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
166,15060719.txt,,collagen-induced arthritis,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
167,15060719.txt,,collagen-induced arthritis,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
168,15060719.txt,,collagen-induced arthritis,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
169,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
170,15060719.txt,,collagen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
171,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
172,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
173,15060719.txt,,collagen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
174,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
175,15060719.txt,,collagen-induced arthritis,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
176,15060719.txt,,collagen-induced arthritis,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
177,15060719.txt,,collagen-induced arthritis,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
178,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
179,15060719.txt,,collagen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
180,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
181,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
182,15060719.txt,,collagen-induced arthritis,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
183,15060719.txt,,collagen-induced arthritis,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
184,15060719.txt,,collagen-induced arthritis,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
185,15060719.txt,,collagen-induced arthritis,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
186,15060719.txt,,collagen-induced arthritis,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
187,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
188,15060719.txt,,carrageenan,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
189,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
190,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
191,15060719.txt,,carrageenan,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
192,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
193,15060719.txt,,carrageenan,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
194,15060719.txt,,carrageenan,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
195,15060719.txt,,carrageenan,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA-1,,
196,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
197,15060719.txt,,carrageenan,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
198,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
199,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
200,15060719.txt,,carrageenan,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
201,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
202,15060719.txt,,carrageenan,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
203,15060719.txt,,carrageenan,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
204,15060719.txt,,carrageenan,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",DBA/1LacJ,,
205,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
206,15060719.txt,,carrageenan,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
207,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
208,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
209,15060719.txt,,carrageenan,mice,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
210,15060719.txt,,carrageenan,mice,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
211,15060719.txt,,carrageenan,rats,"PTK787/ZK222584 treatment caused dose dependent reduction in the 
vascularity of the granulomatous air pouch model.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
212,15060719.txt,,carrageenan,rats,"It inhibited knee swelling by 
40% in antigen-induced arthritis, at the dose of 30 mg/kg p.o., once daily 
(s.i.d). and inhibited both severity scores (by 51%) and global histological 
scores in mice with collagen-induced arthritis following oral treatment (45 
mg/kg p.o.), as compared to control animals.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
213,15060719.txt,,carrageenan,rats,"PTK787/ZK222584 demonstrated no 
effects on inflammatory mediators in the VEGF-independent rat carrageenan model 
and displayed interesting analgesic activity in the Randall Selitto test in the 
acute setting.",angiogenesis inhibitor,PTK787/ZK222584,"receptor tyrosine 
kinase inhibitor",OFA,,
214,15182735.txt,,collagen-induced arthritis,rat,"Treatment with 300 mg/kg/day of DAA 
completely prevented the development of CIA based on the reduction of the 
arthritis score.",immunosuppressive,deer antler aqua-acupuncture,inhibitor of dihydroorotate dehydrogenase,Sprague-Dawley,,
215,15182735.txt,,collagen-induced arthritis,rat,"Treatment with 300 mg/kg/day of DAA 
completely prevented the development of CIA based on the reduction of the 
arthritis score.",immunoactivating,deer antler aqua-acupuncture,inhibitor of dihydroorotate dehydrogenase,Sprague-Dawley,,
216,15205911.txt,rheumatoid arthritis,collagen-induced arthritis,mouse,"These results 
indicate that the HIV vector-mediated expression of angiostatin efficiently 
inhibits the progression of collagen-induced arthritis.",,HIV-angiostatin,,,,
217,15249666.txt,rheumatoid arthritis,peptidoglycan-polysaccharide arthritis,rat,"PPI-2458 significantly 
attenuated paw swelling when therapeutically administered after the onset of 
chronic disease.",,PPI-2458,,,"methionine aminopeptidase-2 (MetAP-2) 
inhibitors",
218,15336954.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"The increase 
in hindpaw volume and joint destruction was suppressed by single therapeutic 
administration (days 15-20) of Y-40138 (30 mg/kg, p.o.), but not by prophylactic 
administration (days 1-9).",,Y-40138,,,,
219,15336954.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"arthritic progression was suppressed by 
single prophylactic administration of methotrexate (0.3 mg/kg, p.o.), but not by 
therapeutic administration.",,Y-40138,,,,
220,15336954.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"The increase 
in hindpaw volume and joint destruction was suppressed by single therapeutic 
administration (days 15-20) of Y-40138 (30 mg/kg, p.o.), but not by prophylactic 
administration (days 1-9).",,methotrexate,,,,
221,15336954.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"arthritic progression was suppressed by 
single prophylactic administration of methotrexate (0.3 mg/kg, p.o.), but not by 
therapeutic administration.",,methotrexate,,,,
222,15338486.txt,rheumatoid arthritis.,adjuvant arthritis,rat,"MTX prevents loss of BMD in the tibia in the rat AA model compared 
to positive controls.",,methotrexate,,Lewis,,
223,15494349.txt,Rheumatoid arthritis,collagen-induced arthritis,mice,etoposide completely inhibited development of arthritis,immunosuppressive,mitoxantrone,topoisomerase II inhibition,DBA/1,,
224,15494349.txt,Rheumatoid arthritis,collagen-induced arthritis,mice,"mitoxantrone after collagen II immunization or high-dose treatment after 
collagen II booster delayed the onset of arthritis",immunosuppressive,mitoxantrone,topoisomerase II inhibition,DBA/1,,
225,15494349.txt,Rheumatoid arthritis,collagen-induced arthritis,mice,etoposide completely inhibited development of arthritis,immunosuppressive,etoposide,topoisomerase II inhibition,DBA/1,,
226,15494349.txt,Rheumatoid arthritis,collagen-induced arthritis,mice,"mitoxantrone after collagen II immunization or high-dose treatment after 
collagen II booster delayed the onset of arthritis",immunosuppressive,etoposide,topoisomerase II inhibition,DBA/1,,
227,15542040.txt,rheumatoid arthritis,ovariectomized,rat,"everolimus directly inhibits bone 
resorption by osteoclasts and thus could at least be neutral or protective for 
bone in vivo",proliferation inhibitor of the macrolide class,everolimus,,,,
228,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",rat,methotrexate showed no suppression,,R-130823,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
229,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",rat,"R-130823 is 
expected to be an efficacious treatment",,R-130823,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
230,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",murine,methotrexate showed no suppression,,R-130823,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
231,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",murine,"R-130823 is 
expected to be an efficacious treatment",,R-130823,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
232,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",rat,methotrexate showed no suppression,,methotrexate,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
233,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",rat,"R-130823 is 
expected to be an efficacious treatment",,methotrexate,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
234,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",murine,methotrexate showed no suppression,,methotrexate,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
235,15627439.txt,rheumatoid arthritis,"collagen-induced arthritis,",murine,"R-130823 is 
expected to be an efficacious treatment",,methotrexate,"highly selective inhibition against mitogen-activated protein kinase 
p38alpha",,,adjuvant-induced arthritis
236,15680277.txt,rheumatoid arthritis,"adjuvant 
induced arthritis",rat,"successfully 
suppressed joint destruction and suggest that FR217840 may have potential as a 
novel anti-rheumatic drug",,FR217840,MMP inhibitor,Lewis,,
237,15693002.txt,rheumatoid arthritis,Collagen-induced arthritis,monkey,"might have a strong clinical potential for treatment during periods of active 
inflammation",,SCH-X,antagonist of CCR5,rhesus,,
238,15844831.txt,rheumatoid arthritis,carrageenan,rats,did not have any anti-nociceptive action,anti-inflammatory,CML-1,,,,
239,15844831.txt,rheumatoid arthritis,carrageenan,rats,"CML-1 has a potent anti-inflammatory 
activity",anti-inflammatory,CML-1,,,,
240,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,did not have any anti-nociceptive action,anti-inflammatory,CML-1,,,,
241,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,"CML-1 has a potent anti-inflammatory 
activity",anti-inflammatory,CML-1,,,,
242,15844831.txt,rheumatoid arthritis,carrageenan,rats,did not have any anti-nociceptive action,analgesic,CML-1,,,,
243,15844831.txt,rheumatoid arthritis,carrageenan,rats,"CML-1 has a potent anti-inflammatory 
activity",analgesic,CML-1,,,,
244,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,did not have any anti-nociceptive action,analgesic,CML-1,,,,
245,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,"CML-1 has a potent anti-inflammatory 
activity",analgesic,CML-1,,,,
246,15844831.txt,rheumatoid arthritis,carrageenan,rats,did not have any anti-nociceptive action,anti-inflammatory,CML-1,,,,
247,15844831.txt,rheumatoid arthritis,carrageenan,rats,"CML-1 has a potent anti-inflammatory 
activity",anti-inflammatory,CML-1,,,,
248,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,did not have any anti-nociceptive action,anti-inflammatory,CML-1,,,,
249,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,"CML-1 has a potent anti-inflammatory 
activity",anti-inflammatory,CML-1,,,,
250,15844831.txt,rheumatoid arthritis,carrageenan,rats,did not have any anti-nociceptive action,analgesic,CML-1,,,,
251,15844831.txt,rheumatoid arthritis,carrageenan,rats,"CML-1 has a potent anti-inflammatory 
activity",analgesic,CML-1,,,,
252,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,did not have any anti-nociceptive action,analgesic,CML-1,,,,
253,15844831.txt,rheumatoid arthritis,Freund's adjuvant,rats,"CML-1 has a potent anti-inflammatory 
activity",analgesic,CML-1,,,,
254,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"Celecoxib significantly inhibited 
paw swelling, hyperalgesic response, and joint destruction (radiographic and 
histopathological findings) in these arthritic rats.",,celecoxib,"celecoxib, a specific cyclooxygenase (COX)-2 
inhibitor",Lewis,,
255,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"These effects of celecoxib 
were superior to those of loxoprofen.",,celecoxib,"celecoxib, a specific cyclooxygenase (COX)-2 
inhibitor",Lewis,,
256,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"Celecoxib significantly inhibited 
paw swelling, hyperalgesic response, and joint destruction (radiographic and 
histopathological findings) in these arthritic rats.",,celecoxib,"loxoprofen, a non-selective COX inhibitor.",Lewis,,
257,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"These effects of celecoxib 
were superior to those of loxoprofen.",,celecoxib,"loxoprofen, a non-selective COX inhibitor.",Lewis,,
258,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"Celecoxib significantly inhibited 
paw swelling, hyperalgesic response, and joint destruction (radiographic and 
histopathological findings) in these arthritic rats.",,loxoprofen,"celecoxib, a specific cyclooxygenase (COX)-2 
inhibitor",Lewis,,
259,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"These effects of celecoxib 
were superior to those of loxoprofen.",,loxoprofen,"celecoxib, a specific cyclooxygenase (COX)-2 
inhibitor",Lewis,,
260,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"Celecoxib significantly inhibited 
paw swelling, hyperalgesic response, and joint destruction (radiographic and 
histopathological findings) in these arthritic rats.",,loxoprofen,"loxoprofen, a non-selective COX inhibitor.",Lewis,,
261,15862805.txt,"rheumatoid 
arthritis,",adjuvant-induced arthritis,rats,"These effects of celecoxib 
were superior to those of loxoprofen.",,loxoprofen,"loxoprofen, a non-selective COX inhibitor.",Lewis,,
262,15883746.txt,"rheumatoid 
arthritis.",adjuvant arthritis,rat,"These observations suggest that glucosamine is able to suppress the 
progression of adjuvant arthritis in rats.",anti-inflammatory,glucosamine,,Wistar,,
263,15899029.txt,Rheumatoid arthritis,adjuvant-induced,HLA-B27,"In both models, a near complete reversal in hindpaw scores 
was observed as well as marked improvements in the histological scores.",suppression of inflammation,WAY-169916,"inhibits 
NF-kappaB transcriptional activity",Lewis,,
264,15899029.txt,Rheumatoid arthritis,adjuvant-induced,rat,"In both models, a near complete reversal in hindpaw scores 
was observed as well as marked improvements in the histological scores.",suppression of inflammation,WAY-169916,"inhibits 
NF-kappaB transcriptional activity",Lewis,,
265,15912568.txt,rheumatoid arthritis,adjuvant arthritis,,"The results of this study indicate that SA can be considered to be a good 
therapeutic agent for inflammation and arthritis.",,"milk extract of Semecarpus anacardium 
Linn. nuts (SA)",,,,
266,15921024.txt,Rheumatoid arthritis,adjuvant arthritis,rat,"Our data demonstrate that MTX was able 
to significantly suppress cytokine and chemokine release in the inflamed joints 
in a dose-dependent fashion, accompanied by amelioration of the disease as 
indicated by reduced paw swelling and arthritic scores.",anti-inflammatory,Methotrexate,,,,
267,15934059.txt,rheumatoid arthritis,"collagen-induced 
arthritis",rats,"combination therapy with M40403 and DEX 
reduced the degree of chronic inflammation and tissue and bone damage",,"combination therapy with M40403, a 
superoxide dismutase mimetic (SODm), and dexamethasone (DEX)",,Lewis,,
268,15971419.txt,rheumatoid arthritis,"adjuvant-induced 
arthritis",rats,"fenofibrate 
inhibits the development of arthritis",,fenofibrate,ligand for PPAR-alpha,Lewis,,
269,16049391.txt,rheumatoid arthritis,,rats,"M2000 significantly 
reduces paw edema and histopathological parameters in arthritic rats.",anti-inflammatory,"M2000 
(beta-D-mannuronic acid)",,,,
270,16049391.txt,rheumatoid arthritis,,rats,"M2000 significantly 
reduces paw edema and histopathological parameters in arthritic rats.",immunosuppressive,"M2000 
(beta-D-mannuronic acid)",,,,
271,16049391.txt,rheumatoid arthritis,,rats,"M2000 significantly 
reduces paw edema and histopathological parameters in arthritic rats.",non-steroidal anti-inflammatory drug,"M2000 
(beta-D-mannuronic acid)",,,,
272,16059892.txt,rheumatoid arthritis,carrageenan,mice,observed resistance to MTX in DBA/1J mice.,,methotrexate,,C57BL/6J,,
273,16059892.txt,rheumatoid arthritis,carrageenan,mice,observed resistance to MTX in DBA/1J mice.,,methotrexate,,BALB/cJ,,
274,16059892.txt,rheumatoid arthritis,carrageenan,mice,observed resistance to MTX in DBA/1J mice.,,methotrexate,,DBA/1J,,
275,16059892.txt,rheumatoid arthritis,carrageenan,mice,observed resistance to MTX in DBA/1J mice.,,methotrexate,,DBA/2J,,
276,16095110.txt,rheumatoid arthritis,adjuvant arthritis,rat,"LY329201 as well 
as methotrexate demonstrated a dose dependent reduction in both paw and spleen 
weight and improved joint histology following 2 weeks of dosing in a rat 
adjuvant arthritis study.",,LY329201,"glycinamide ribonucleotide 
formyltransferase (GARFT) inhibitor",,,
277,16095110.txt,rheumatoid arthritis,adjuvant arthritis,rat,"LY329201 as well 
as methotrexate demonstrated a dose dependent reduction in both paw and spleen 
weight and improved joint histology following 2 weeks of dosing in a rat 
adjuvant arthritis study.",,methotrexate,"glycinamide ribonucleotide 
formyltransferase (GARFT) inhibitor",,,
278,18612926.txt,rheumatoid arthritis,collagen-induced arthritis,mouse,"AD significantly mitigated the severity of the arthritis and 
histopathological findings indicative of RA in CIA mice.",inflammation modulator,Adiponectin,,DBA/1,,
279,18652917.txt,"rheumatoid 
arthritis.",collagen II (CII)-induced arthritis (CIA),mice,"It was concluded that 
madecassoside substantially prevented mouse CIA, and might be the major active 
constituent of C. asiatica herbs responsible for clinical uses for rheumatoid 
arthritis.","regulating 
the abnormal humoral and cellular immunity as well as protecting joint 
destruction.",madecassoside,,,,
280,18668557.txt,rheumatoid arthritis,collagen-induced arthritis,mice,"Our findings indicate that intravenous 
administration of a lipoplex cocktail containing several anticytokine siRNA is a 
promising novel antiinflammatory therapy for RA",antiinflammatory,"RNA interference (RNAi)-based intervention that targets 
proinflammatory cytokines",,DBA/1,,
281,18685219.txt,"rheumatoid 
arthritis.",adjuvant arthritis,rat,"suggest that CH had 
a suppressive effect on adjuvant arthritis","inhibiting the acute and chronic 
inflammatory reactions.","casein hydrolysate (CH) prepared from Aspergillus 
oryzae protease",,,,
282,18758904.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"This inflammatory bone 
destruction was suppressed potently by celecoxib, only moderately by loxoprofen, 
and not at all by SC-58560.",,celecoxib,"COX-2-specific (celecoxib), COX-nonselective (loxoprofen), and COX-1-specific 
agents (SC-58560)",Lewis,,
283,18758904.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"This inflammatory bone 
destruction was suppressed potently by celecoxib, only moderately by loxoprofen, 
and not at all by SC-58560.",,loxoprofen,"COX-2-specific (celecoxib), COX-nonselective (loxoprofen), and COX-1-specific 
agents (SC-58560)",Lewis,,
284,18758904.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"This inflammatory bone 
destruction was suppressed potently by celecoxib, only moderately by loxoprofen, 
and not at all by SC-58560.",,SC-58560,"COX-2-specific (celecoxib), COX-nonselective (loxoprofen), and COX-1-specific 
agents (SC-58560)",Lewis,,
285,18792999.txt,Rheumatoid arthritis,collagen-induced arthritis,rat,"Our results indicate that 2ME2 may represent a novel agent for the 
treatment of inflammatory autoimmune diseases such as RA.",antiangiogenic,2-Methoxyestradiol (2ME2),,,,
286,18792999.txt,Rheumatoid arthritis,collagen-induced arthritis,rat,"Our results indicate that 2ME2 may represent a novel agent for the 
treatment of inflammatory autoimmune diseases such as RA.",antiproliferative,2-Methoxyestradiol (2ME2),,,,
287,18796608.txt,rheumatoid arthritis,adjuvant-induced arthritis,rat,"The results of 
these studies provide previously undescribed evidence of IL-6 synthesis and 
transsignaling inhibition by EGCG with a unique mechanism of sgp130 
up-regulation, and thus hold promise as a potential therapeutic agent for RA.",anti-inflammatory,epigallocatechin-3-gallate (EGCG),"inhibits IL-1beta-induced IL-6 production and transsignaling 
in RA synovial fibroblasts by inducing alternative splicing of gp130 mRNA, 
resulting in enhanced sgp130 production.",,,
